INTENSITY THERAPEUTICS, INC. Earnings Per Share (Basic)
INTENSITY THERAPEUTICS, INC. (INTS) reported Earnings Per Share (Basic) of -$1.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.11.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.96.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.06.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$3.36.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$8.56.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$29.24.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$1.38.
- INTENSITY THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.22.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.11 10-Q · filed 2026-08-11 | -$2.08 10-Q · filed 2026-08-11 | |||||
| 2026-03-31 | -$0.96 10-Q · filed 2026-05-07 | ||||||
| 2025-12-31 | -$8.56 10-K · filed 2026-03-27 | ||||||
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-06 | -$0.33 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | -$3.36 10-Q · filed 2026-08-11 | -$0.13 10-Q · filed 2025-08-07 | -$8.64 10-Q · filed 2026-08-11 | -$0.35 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | -$5.51 10-Q · filed 2026-05-07 | -$0.22 10-Q · filed 2025-05-13 | |||||
| 2024-12-31 | -$29.24 10-K · filed 2026-03-27 | -$1.17 10-K · filed 2025-03-13 | |||||
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-06 | -$0.95 10-Q · filed 2025-11-06 | |||||
| 2024-06-30 | -$0.36 10-Q · filed 2025-08-07 | -$0.70 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | -$0.34 10-Q · filed 2025-05-13 | ||||||
| 2023-12-31 | -$1.38 10-K · filed 2025-03-13 | ||||||
| 2023-09-30 | -$0.17 10-Q · filed 2024-11-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.26 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | -$1.43 10-Q · filed 2024-08-08 | -$1.05 10-Q · filed 2023-08-14 | -$1.84 10-Q · filed 2024-08-08 | -$1.45 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | -$0.39 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | -$2.22 10-K · filed 2024-03-14 | ||||||
| 2022-09-30 | -$0.52 10-Q · filed 2023-11-13 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.78 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.57 10-Q · filed 2023-08-14 | -$1.26 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |